预防用药差错国际培训班（西宁）最新培训议程7.23-24

预防用药差错国际培训班（西宁）最新培训议程
**USP Pharmacy Workshop**

Understanding and Preventing Medication Errors

美国药典委员会药学研讨会-了解、预防用药差错

(Xi Ning – 2 Day program)

西宁-2天

Learning Objectives:  After attending this workshop, participants will be able to:

学习目标：通过本次研讨会，与会者将能够

Ø  Understand key medication error terminology including types, causes and the differences between a medication error, adverse drug reaction and adverse drug event

了解用药差错术语（类型、原因）及用药差错、不良反应和药物不良事件之间的差异

Ø Categorize the severity of a medication error using a standardized indexing tool developed by a panel of patient safety experts

通过利用患者安全专家平台开发出的标准索引工具，对用药差错的严重程度进行分类。

Ø Describe a variety of methods that can be used to identify medication safety risks within a hospital or other healthcare facilities

描述能够在医院或其他医疗机构中鉴别药物安全风险的几种方法

Ø Use proven safety tools to investigate system-based causes of error and reach conclusions on the actions that should be taken that result from successful error analysis

使用经证明有效的安全工具调查用药差错的系统性原因，并通过成功的差错分析，采取措施从而找到结论。

Ø Set priorities for risk-reduction strategies and learn the strength levels of these different strategies

建立降低风险策略的优先次序，学习这些不同策略的优势水平。

Program Agenda – Day 1 议程-第一天 （7.23）

Ø Error Terminology and Categorization   用药差错术语和分类

o   Differentiate between errors and other types of adverse drug events

用药差错与其他类型药物不良事件间的差异

o   Understand the basic framework for categorizing errors by severity, type, and cause

理解根据严重程度、类型和原因分类用药差错的基本框架

o   Case Studies: use real error cases to practice using a standardized indexing tool

案例研究：通过真实的用药差错案例练习使用标准索引工具

Ø Risk Analysis:  Individual Report Analysis   风险分析：个别报告分析

o   Learn to examine error events from a system-based perspective rather than blaming individuals

学习从系统化的角度审视用药差错事件而不是归咎于个别事件

o   Learn the 10 key safety elements that provide the foundation for in-depth examination of the potential medication system weaknesses  

学会关于深入检验潜在的药品系统弱点的10个重要安全要素

o   Understand the role of latent failures and active failures to better understand how errors occur

了解隐性失效和显性失效，以便更好地理解用药差错是如何发生的

o   Case Studies: use an individual error event to examine and analyze the 10 key safety elements

案例研究：通过个别用药差错事件检验并分析10个重要安全要素

Ø Discussion / Question and Answer Session 讨论/问答环节



Program Agenda – Day 2 议程-第二天（7.24）

Ø Risk Identification Part I:  Medication Error Reporting Programs

风险识别 I：用药差错报告程序

o   Understand the various data collection methods for spontaneous reporting of error events

了解收集用药差错事件自发报告数据的多种方法

o   Learn the advantages and disadvantages of reporting programs

学习报告程序的优缺点

Ø Risk Identification Part II:  Identifying Risk Beyond Reporting Programs

风险识别 II：识别风险重于报告程序

o   Learn proven safety tools to proactively, concurrently, and retrospectively assess risk  

学习利用已被证明安全的工具前摄性地、并发性地及回顾性地对风险进行评估。

Ø  Risk Analysis:  Evaluating Aggregate Data   风险分析：评估综合资料

o   Learn to transform aggregate error data into meaningful information and display results in tables and charts

学习将综合用药差错数据转换为有意义的信息并在图表中显示结果

o   Breakout Session – workgroups to review aggregate medication error data from a US hospital and answer a series of questions.

分组讨论-小组讨论某美国医院的综合用药差错数据，回答一系列问题

Ø Risk Control:  Choosing Effective Error Reduction Strategies

风险控制：选择有效减少用药差错的策略

o   Explain the goals and principles of medication error prevention and harm reduction, and learn the difference between high and low leverage strategies

说明预防用药差错和减少损害的目标和原则，学习不同层次策略的差异

Ø Examining Interventions:  Assessing Impact of Error Reduction Strategies

检验干预：评估减少用药差错策略带来的影响

o   Learn which questions about developing an action plan, weighting of actions, and first and second order changes

学习创立一项活动计划、衡量活动质量和第一第二层次将涉及的问题

Discussion / Question and Answer Session   讨论/问答环节

http://www.cpa.org.cn/Article/xhdt/201106/1528.asp